•By the end of the workshop, several weaknesses, gaps, challenges and possible solutions have been identified.•Via two questionnaires we have identified an increase in awareness and knowledge in nutrition and funding opportunities.•A strong interest in creating new collaborations with researchers outside Morocco has been clearly shown.

This study describes the distribution of glycosylated haemoglobin (Hb A1c ) and glucose concentrations in the combined year 1 (2008–2009), year 2 (2009–2010) and year 3 (2010–2011) of the National Diet and Nutrition Survey (NDNS) rolling programme. The NDNS rolling programme is a nationally representative survey of food consumption, nutrient intakes and nutritional status of people aged 1.5 years and over living in England, Wales, Scotland and Northern Ireland. The study population comprised survey members who completed three or four days of dietary recording and who provided a blood sample. After excluding survey members with self-reported diabetes (n=25), there were 1016 results for Hb A1c and 942 for glucose (not the same individuals in each case). Around 5.4% of men and 1.7% of women aged 19–64 years, and 5.1% of men and 5.9% of women aged ≥65 years had impaired fasting glucose (glucose concentrations 6.1–6.9 mmol/L). Over 20% of men aged ≥65 years had fasting glucose concentrations above the clinical cut-off for diabetes (≥7 mmol/L) compared to 2.1% of women of similar age (p=0.007). Similarly, 16.4% of men had Hb A1c concentrations ≥6.5%, compared to 1.5% of women (p=0.003). Children and teenagers had fasting glucose and Hb A1c values largely within the normal range. To conclude, this is the first study to provide data on the distribution of Hb A1c and glucose concentrations in a nationally representative sample of the British population. The high prevalence of men aged ≥65 years with Hb A1c and glucose concentrations above the clinical cut-off of diabetes warrants further attention.

Y.

infectious and parasitic (1.57, 1.07 to 2.29), genitourinary (1.46, 1.04 to 2.04), circulatory (1.07, 1.01 to 1.12), and external (non-medical) (1.17, 1.00 to 1.37) causes and decreased for deaths attributed to in situ, benign and unspecified neoplasms (0.60, 0.37 to 0.99).There was no clear relation between chemical exposure group and causespecific mortality.The mortality of each group was lower than that of the general population (SMR 0.88, 0.85 to 0.90; 0.82, 0.80 to 0.84 respectively).3457 cancers were reported in Porton Down veterans and 3380 in non-Porton Down veterans.While overall cancer morbidity was the same (RR 1.00, 95% CI 0.95 to 1.05), Porton Down veterans had higher rates of ill-defined malignant neoplasms (1.12; 1.02 to 1.22), in situ neoplasms (1.45; 1.06 to 2.00) and those of uncertain or unknown behaviour (1.32; 1.01 to 1.73).Conclusions: Mortality was slightly higher in Porton Down than non-Porton Down veterans.With the lack of information on other important factors, such as smoking or service overseas, it is not possible to attribute the small excess mortality to chemical exposures at Porton Down.Overall cancer morbidity in Porton Down veterans was no different from that in non-Porton Down veterans.